Palovarotene is a synthetic retinoic acid receptor γ (RARγ) agonist that was first described in studies several years ago1 and was recently approved for the treatment of fibrodysplasia ossificans progressiva (FOP). Here, RARG is linked to fibrodysplasia ossificans progressiva.